NIH-funded research R01 grant

Understanding how glucose transport affects brain development and disorders

Official title: Determining the Role of Glucose Transporter 1 in Neural Development and Disease

Funded at Weill Medical Coll of Cornell Univ · NIH-11132125 · Data updated 2026-11-12

This study is looking at how a protein called GLUT1 helps the brain grow and develop, and how problems with this protein might be connected to conditions like Autism and Attention Deficit Disorder, using both mice and human samples to learn more about it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2025
Project endJanuary 31, 2030
Funding year2025
Award (this year)$595,779
NIH project number1R01NS138625-01A1
Project IDNIH-11132125 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with GLUT1-Deficiency Syndrome or those diagnosed with Autism or Attention Deficit Disorder.

Less likely to help

Patients without neurodevelopmental disorders or those not affected by glucose metabolism issues may not benefit from this research.

What this research studies

This research investigates the role of a specific glucose transporter, GLUT1, in the development of the brain and its potential link to neurodevelopmental disorders such as Autism and Attention Deficit Disorder. By studying both mouse and human models, the researchers aim to understand how glucose uptake influences the growth and differentiation of neural progenitor cells during brain development. The study will utilize advanced techniques to analyze how changes in GLUT1 expression can affect brain cell behavior and overall neurodevelopment.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for neurodevelopmental disorders linked to glucose metabolism.

How similar studies have gone: Previous research has shown promising results in understanding the role of glucose metabolism in brain development, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Pearson, Caroline Alayne — Weill Medical Coll of Cornell Univ
  • Study coordinator: Pearson, Caroline Alayne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.